Literature DB >> 26617845

Establishment of pancreatic cancer stem cells by flow cytometry and their biological characteristics.

Dandan Li1, Dongyue Su1, Lei Xue1, Yang Liu1, Wuyan Pang1.   

Abstract

To investigate the method of separating human pancreatic cancer stem cells by Hoechst 33342 labeled flow cytometry and to analyze the biological properties of pancreatic cancer stem cells. The human pancreatic cancer cell line PC-3 was divided into SP and non-SP cells by flow cytometry. The number of two cell clone spheres and nude mice tumor formation rates were compared by cultivating in serum-free medium; The expression of CD133, Nestin mRNA and protein was analyzed by real-time fluorescence quantitative PCR and Western blot; The expression of two cell drug resistance genes (MDR1, ABCG2, ABCA2 and MRP1) was analyzed by real time fluorescent quantitative PCR. The number of the cloned spheres in SP cells in serum-free medium was significantly higher than that of non-SP cells (P<0.05). The incidence of SP cells in the tumor of immunodeficiency nude mice was significantly higher than that of non-SP cells, and the difference was statistically significant (P<0.05). Real-time fluorescence quantitative PCR analysis showed that the expression of CD133 and Nestin mRNA in SP cells was significantly higher than those of non-SP cells, and the expression of CD133 and Nestin protein in SP cells was also significantly higher than those of non-SP cells (P<0.05). In conclusion, SP side population pancreatic cancer cells by Hoechst 33342 separation have the stem cell characteristics, higher tumor formation rate and higher drug resistance, which may be related to chemotherapy resistance.

Entities:  

Keywords:  Pancreatic cancer stem cells; SP cells; flow cytometry; non-SP cells

Mesh:

Substances:

Year:  2015        PMID: 26617845      PMCID: PMC4637660     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

Review 1.  Chemotherapy and immunotherapy of brain tumors: what the epileptologist must know.

Authors:  Lisa R Rogers
Journal:  Epilepsia       Date:  2013-12       Impact factor: 5.864

2.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Authors:  Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

Review 3.  Brain stem cells as the cell of origin in glioma.

Authors:  Aram S Modrek; N Sumru Bayin; Dimitris G Placantonakis
Journal:  World J Stem Cells       Date:  2014-01-26       Impact factor: 5.326

4.  Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.

Authors:  Yue Zhao; Lu Zhao; Ivan Ischenko; Qi Bao; Bettina Schwarz; Hanno Nieß; Yan Wang; Andrea Renner; Josef Mysliwietz; Karl-Walter Jauch; Peter J Nelson; Joachim W Ellwart; Christiane J Bruns; Peter Camaj
Journal:  Target Oncol       Date:  2015-02-03       Impact factor: 4.493

5.  Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.

Authors:  Lubna Patrawala; Tammy Calhoun; Robin Schneider-Broussard; Jianjun Zhou; Kent Claypool; Dean G Tang
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

6.  MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1.

Authors:  Katja Engelmann; Hongmei Shen; Olivera J Finn
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

7.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

8.  Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.

Authors:  Maria M Ho; Alvin V Ng; Stephen Lam; Jaclyn Y Hung
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

9.  Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802.

Authors:  Edward G Shaw; Meihua Wang; Stephen W Coons; David G Brachman; Jan C Buckner; Keith J Stelzer; Geoffrey R Barger; Paul D Brown; Mark R Gilbert; Minesh P Mehta
Journal:  J Clin Oncol       Date:  2012-07-30       Impact factor: 44.544

10.  Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.

Authors:  Sara Häggblad Sahlberg; Diana Spiegelberg; Bengt Glimelius; Bo Stenerlöw; Marika Nestor
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

View more
  6 in total

Review 1.  ATP-binding cassette transporter-2 (ABCA2) as a therapeutic target.

Authors:  Warren Davis; Kenneth D Tew
Journal:  Biochem Pharmacol       Date:  2017-12-06       Impact factor: 5.858

2.  Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells.

Authors:  Srikanth Barkeer; Seema Chugh; Saswati Karmakar; Garima Kaushik; Sanchita Rauth; Satyanarayana Rachagani; Surinder K Batra; Moorthy P Ponnusamy
Journal:  BMC Cancer       Date:  2018-11-22       Impact factor: 4.430

3.  Radioactive 125I seed implantation for pancreatic cancer with unexpected liver metastasis: A preliminary experience with 26 patients.

Authors:  Cheng-Gang Li; Zhi-Peng Zhou; Yu-Ze Jia; Xiang-Long Tan; Yu-Yao Song
Journal:  World J Clin Cases       Date:  2021-02-06       Impact factor: 1.337

4.  In vitro and ex vivo anti‑tumor effect and mechanism of Tucatinib in leukemia stem cells and ABCG2‑overexpressing leukemia cells.

Authors:  Wen Jing; Mao Zhou; Ruixia Chen; Xijiu Ye; Weixing Li; Xiangfei Su; Jianwei Luo; Zhi Wang; Shuling Peng
Journal:  Oncol Rep       Date:  2020-12-30       Impact factor: 3.906

5.  Calreticulin is highly expressed in pancreatic cancer stem-like cells.

Authors:  Satoshi Matsukuma; Kiyoshi Yoshimura; Tomio Ueno; Atsunori Oga; Moeko Inoue; Yusaku Watanabe; Atsuo Kuramasu; Masanori Fuse; Ryouichi Tsunedomi; Satoshi Nagaoka; Hidetoshi Eguchi; Hiroto Matsui; Yoshitaro Shindo; Noriko Maeda; Yoshihiro Tokuhisa; Reo Kawano; Tomoko Furuya-Kondo; Hiroshi Itoh; Shigefumi Yoshino; Shoichi Hazama; Masaaki Oka; Hiroaki Nagano
Journal:  Cancer Sci       Date:  2016-11-04       Impact factor: 6.716

6.  Radioactive 125I seed implantation for locally advanced pancreatic cancer: A retrospective analysis of 50 cases.

Authors:  Cheng-Gang Li; Zhi-Peng Zhou; Yu-Ze Jia; Xiang-Long Tan; Yu-Yao Song
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.